Manganese Complex of Ethylenediaminetetraacetic Acid (EDTA)-Benzothiazole Aniline (BTA) Conjugate as a Potential Liver-Targeting MRI Contrast Agent

A novel manganese(II) complex based on an ethylenediaminetetraacetic acid (EDTA) coordination cage bearing a benzothiazole aniline (BTA) moiety (Mn-EDTA-BTA) was designed and synthesized for use as a liver-specific MRI contrast agent with high chelation stability. In addition to forming a hydrophili...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 60; no. 7; pp. 2993 - 3001
Main Authors Islam, Md. Kamrul, Kim, Soyeon, Kim, Hee-Kyung, Park, Subin, Lee, Gang-Ho, Kang, Hyo Jeung, Jung, Jae-Chang, Park, Joon-Suk, Kim, Tae-Jeong, Chan, Yongmin
Format Journal Article
LanguageEnglish
Published WASHINGTON Amer Chemical Soc 13.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel manganese(II) complex based on an ethylenediaminetetraacetic acid (EDTA) coordination cage bearing a benzothiazole aniline (BTA) moiety (Mn-EDTA-BTA) was designed and synthesized for use as a liver-specific MRI contrast agent with high chelation stability. In addition to forming a hydrophilic, stable complex with Mn2+, this new Mn chelate was rapidly taken up by liver hepatocytes and excreted by the kidneys and biliary system. The kinetic inertness and R-1 relaxivity of the complex were much higher than those of mangafodipir trisodium (MnDPDP), a clinically approved liver-specific MRI contrast agent. The diagnostic utility of this new Mn complex in MRI was, demonstrated by high-sensitivity tumor detection in an animal model of liver cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.6b01799